148 Real-world outcomes to assess efficacy of first-line Osimertinib in advanced EGFR-mutated NSCLC

Lung Cancer 2026

View at publisher

Authors: Waseem Barkt Ali, Jhanzeb Iftkhar, Gary Middleton, Mabel Teng, Qamar Ghafoor, Steven Watkins, Teresa Chu, Oliver J. Pickles

DOI: 10.1016/j.lungcan.2026.109097

Cited by: 0

References: 2

Fields of Study & Subjects

Lung Cancer Treatments and Mutations Lung Cancer Diagnosis and Treatment HER2/EGFR in Cancer Research

References 2